| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Lisa McClain MI09 | 1 | 1 | +$0 | Sold Jul 10, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Jul 10, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Aug 13, 25 (34d) | |
| Jun 17, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (57d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Hensley Robert EdwardChief Investment Officer | Sale at price 169.53 - 170.34 per share. | 10K | $1.70M |
| Sep 21, 2026 | Hensley Robert EdwardChief Investment Officer | Conversion of Exercise of derivative security at price 103.23 per share. | 10K | $1.03M |
| Jul 30, 2026 | Darden James MatthewChief Executive Officer | Sale at price 182.43 - 183.36 per share. | 50K | $9.12M |
| Jul 30, 2026 | Darden James MatthewChief Executive Officer | Conversion of Exercise of derivative security at price 98.32 per share. | 50K | $4.92M |
| Jul 29, 2026 | Kalmbach Thomas PeterChief Financial Officer | Sale at price 179.30 - 181.81 per share. | 21K | $3.78M |
| Jul 29, 2026 | Kalmbach Thomas PeterChief Financial Officer | Conversion of Exercise of derivative security at price 103.23 - 120.49 per share. | 21K | $2.36M |
| Jul 28, 2026 | Majors Michael ClayOfficer | Sale at price 178.56 - 179.35 per share. | 37K | $6.61M |
| Jul 28, 2026 | Majors Michael ClayOfficer | Conversion of Exercise of derivative security at price 103.23 per share. | 37K | $3.82M |
| Jul 27, 2026 | Kalmbach Thomas PeterChief Financial Officer | Sale at price 178.06 - 179.42 per share. | 25.6K | $4.58M |
| Jul 27, 2026 | Kalmbach Thomas PeterChief Financial Officer | Conversion of Exercise of derivative security at price 120.49 - 128.40 per share. | 25.6K | $3.18M |
| Jun 29, 2026 | Skarjune Dolores LOfficer | Sale at price 179.18 per share. | 1.9K | $331.48K |
| Jun 29, 2026 | Skarjune Dolores LOfficer | Conversion of Exercise of derivative security at price 103.23 per share. | 1.9K | $190.98K |
| Jun 24, 2026 | Alston Cheryl DDirector | Sale at price 177.56 - 180.57 per share. | 8.3K | $1.48M |
| Jun 24, 2026 | Alston Cheryl DDirector | Conversion of Exercise of derivative security at price 105.56 per share. | 14K | $1.48M |
| Jun 17, 2026 | Zorn Rebecca EOfficer | Sale at price 170.10 per share. | 2K | $340.19K |
| Jun 17, 2026 | Zorn Rebecca EOfficer | Conversion of Exercise of derivative security at price 98.32 per share. | 2K | $196.64K |
| Jun 11, 2026 | Svoboda Frank MChief Executive Officer | Sale at price 164.20 - 166.93 per share. | 20K | $3.32M |
| Jun 11, 2026 | Skarjune Dolores LOfficer | Sale at price 165.58 - 167.25 per share. | 4.2K | $693.79K |
| Jun 11, 2026 | Svoboda Frank MChief Executive Officer | Conversion of Exercise of derivative security at price 100.74 per share. | 20K | $2.01M |
| Jun 11, 2026 | Skarjune Dolores LOfficer | Conversion of Exercise of derivative security at price 98.32 - 103.23 per share. | 4.2K | $418.83K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.3 | 3.6 | -4.2 | 10.9 | -0.7 | 16.6 | 2.0 | -5.3 | -4.1 | -0.3 | +18.1% | ||
| 2025 | 9.5 | 4.4 | 3.4 | -6.4 | -1.2 | 2.0 | 13.0 | -0.4 | 2.2 | -8.0 | 2.4 | 3.8 | +25.4% |
| 2024 | 0.9 | 3.3 | -8.3 | -34.5 | 8.7 | -0.6 | 12.7 | 13.3 | 0.8 | -0.3 | 5.3 | 0.3 | −8.4% |
| 2023 | 0.2 | 0.7 | -9.6 | -1.4 | -4.9 | 6.2 | 2.3 | -0.5 | -2.5 | 7.0 | 5.8 | -1.1 | +1.0% |
| 2022 | 9.2 | -1.3 | -0.4 | -2.5 | -0.5 | -0.1 | 3.3 | -3.5 | 2.6 | 15.9 | 3.8 | 0.5 | +28.6% |
| 2021 | -4.8 | 3.3 | 3.5 | 6.1 | 2.9 | -9.6 | -2.2 | 3.2 | -7.3 | -0.0 | -2.8 | 8.3 | −1.3% |
| 2020 | -0.9 | -11.1 | -22.3 | 14.4 | -6.5 | -3.6 | 7.2 | 3.6 | -3.1 | 1.5 | 14.8 | 2.0 | −9.8% |
| 2019 | 12.4 | -1.4 | -0.7 | 7.0 | -2.5 | 4.6 | 2.1 | -2.3 | 7.3 | 1.6 | 5.6 | 2.4 | +41.2% |
| 2018 | 0.2 | -6.0 | -1.4 | 3.1 | -2.2 | -4.0 | 8.2 | -0.2 | -1.4 | -2.3 | 2.1 | -13.7 | −17.8% |
| 2017 | -0.3 | 5.4 | -0.6 | -0.4 | -1.6 | 1.3 | 3.2 | -2.5 | 4.1 | 5.0 | 5.6 | 2.1 | +23.0% |
| 2016 | -4.9 | -5.7 | 5.7 | 6.9 | 6.5 | 0.3 | 0.1 | 4.5 | -1.2 | -0.8 | 10.5 | 5.2 | +29.0% |
| 2015 | -7.6 | 6.4 | 3.1 | 2.2 | 1.7 | 2.0 | 5.8 | -5.1 | -3.5 | 2.9 | 4.5 | -5.7 | +5.5% |
| 2014 | -3.8 | 3.1 | 1.5 | 1.3 | 1.5 | 1.2 | -3.4 | 3.4 | -4.0 | 1.1 | 1.5 | 0.8 | +4.0% |
| 2013 | 7.8 | 0.9 | 6.4 | 3.8 | 3.9 | 1.0 | 9.1 | -3.1 | 5.0 | 0.7 | 4.3 | 2.8 | +51.2% |
| 2012 | 5.3 | 6.1 | 2.9 | -2.3 | -4.2 | 8.3 | -1.6 | 2.9 | 0.3 | -1.5 | 2.8 | -0.6 | +19.1% |
| 2011 | 4.3 | 4.7 | 1.9 | 0.7 | -0.9 | -3.3 | -5.5 | -5.4 | -8.8 | 17.4 | 4.1 | 1.9 | +8.9% |
| 2010 | 2.2 | 3.6 | 15.1 | 0.1 | -3.8 | -3.9 | 7.2 | -7.0 | 7.7 | 7.8 | 0.3 | 3.9 | +35.9% |
| 2009 | -32.9 | -31.3 | 27.3 | 11.8 | 36.9 | -7.8 | 5.5 | 9.1 | 1.9 | -6.5 | 7.1 | 1.1 | −1.7% |
| 2008 | 0.7 | -1.2 | -0.2 | 7.7 | -2.1 | -7.5 | -1.0 | 2.9 | 0.1 | -30.2 | -13.5 | 23.7 | −26.2% |
| 2007 | 1.9 | -1.6 | 2.6 | 4.1 | 2.7 | -4.4 | -8.1 | 0.0 | 1.2 | 4.6 | -5.3 | -1.9 | −5.1% |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Buy / hold / sell counts